outside chance that Sprycel could be available as a generic in the US market around the same time as a Gleevec generic. An undisclosed party submitted a Sprycel ANDA and Paragraph-IV challenge in Jun 2011:
I think it's very likely just a generic company "getting in line" to be first for exclusivity when the patent finally expires. I've not heard anything to cast any doubt on the Sprycel patents.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.